WASHINGTON (dpa-AFX) - Alnylam Pharmaceuticals Inc. (ALNY) reported Thursday that its third-quarter net loss narrowed to $208.5 million or $1.92 per share from last year's loss of $245.3 million or $2.43 per share last year.
Adjusted net loss was $162.5 million, or $1.50 per share, compared to net loss of $157.3 million, or $1.56 per share a year earlier.
Total revenues surged to $70.06 million from $2.07 billion a year ago.
In pre-market activity, Alnylam shares were gaining around 1.4 percent to trade at $88.50.
Copyright RTT News/dpa-AFX
© 2019 AFX News
